Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Active Not RecruitingNCT04975152What this trial is testingNeoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell CarcinomaWho this might be right forMerkel Cell CarcinomaCutaneous Squamous Cell Carcinoma H. Lee Moffitt Cancer Center and Research Institute 36
Early research (Phase 1)Looking for participantsNCT06021626What this trial is testingCRD3874-SI in People With Solid TumorsWho this might be right forSarcomaMerkel Cell Carcinoma Memorial Sloan Kettering Cancer Center 72
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Looking for participantsNCT07302347What this trial is testingPembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)Who this might be right forMalignant NeoplasmCarcinoma, Merkel CellLymphoma Merck Sharp & Dohme LLC 20
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20
Testing effectiveness (Phase 2)Ended earlyNCT04902040What this trial is testingPlinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesWho this might be right forAdvanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more M.D. Anderson Cancer Center 19
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Looking for participantsNCT05076760What this trial is testingMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer+7 more Memgen, Inc. 40
Early research (Phase 1)Looking for participantsNCT06940440What this trial is testingIFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)Who this might be right forAdvanced Or Metastatic Merkel Cell Carcinoma TuHURA Biosciences, Inc. 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472322What this trial is testingASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1Who this might be right forMerkel Cell CarcinomaMerkel Cell Carcinoma, Stage IIIMerkel Cell Carcinoma, Stage IV University of Wisconsin, Madison 31
Early research (Phase 1)Active Not RecruitingNCT04047251What this trial is testingFF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell CarcinomaWho this might be right forAdvanced Solid TumorsMerkel Cell Carcinoma Fujifilm Pharmaceuticals U.S.A., Inc. 96
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271What this trial is testingBOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsWho this might be right forHepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more Sotio Biotech Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00004922What this trial is testingIrinotecan in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forCarcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT03935893What this trial is testingAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersWho this might be right forGastric CancerColorectal CancerPancreatic Cancer+7 more Udai Kammula 240
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 60
Testing effectiveness (Phase 2)Looking for participantsNCT04349436What this trial is testingStudy to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesWho this might be right forMerkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more Replimune, Inc. 90